Public stakeholder meeting on the approval and roll-out of COVID-19 vaccines in the EU

EMA is organising this open event to:

• explain the basis for the approval and use of the new COVID-19 vaccines and how the safety of the vaccines will be assured;
• provide information on the roles of the European Commission and national public health authorities in the roll-out of the vaccines;
• listen to the needs, expectations and any concerns of the public and stakeholders.

Full video recording

Basis for the EU approval of new vaccines (Presentation by Harald Enzmann, Head of Biological Health Threats and Vaccines Strategy)

How the safety of the new COVID-19 vaccines will be assured (Presentation by Sabine Straus, PRAC chair)

European Commission's role in the authorisation process and facilitation of roll out vaccination (Presentation by John F. Ryan, European Commission)

HMA - Ongoing actions for roll-out vaccination at national level (Presentation by Nikolai Brun, Head of Danish Medicines Agency)